Contact
Please use this form to send email to PR contact of this press release:
Aclaris Therapeutics Initiates Phase 3 Clinical Trials of A-101 for the Treatment of Seborrheic Keratosis
TO:
Please use this form to send email to PR contact of this press release:
Aclaris Therapeutics Initiates Phase 3 Clinical Trials of A-101 for the Treatment of Seborrheic Keratosis
TO: